Epilepsy

Reports Globe’s new report on Global Epilepsy Therapeutics Market provides in-depth coverage of industry and significant market trends with historical and forecast market information, demand, application information, price trends and shares of the leading Epilepsy Therapeutics Company by geography. This report also studies the Epilepsy Therapeutics market share, competitive landscape, …

YouTuber TSM is aiming for the world record in the game marathon, while raising funds for the National Society for Epilepsy. A YouTuber is currently at the end of a mammoth task: playing Final Fantasy 13 for 40 straight hours. As of this writing, streamer TSM has 35 hours of …

New research shows that cells collect more data than once believed inside the thalamus, a relay station for sensory and motor skills in the brain. It could change the way medicine treats schizophrenia, epilepsy, and other brain disorders. Our brains are responsible for coordinating and interpreting many actions we take …

The Jordan Elizabeth Harris Foundation, a non-profit organization providing suicide prevention education and training in North Texas, provided research funding in the amount of $ 49,950 to Dr. Crystal Cooper , a researcher at the Cook Children’s Jane and the John Justin Neuroscience Center. The study is titled: Cognitive biomarkers …

D Carpet companies Pfizer and Flynn have been accused by the UK competition watchdog of abusing their dominant position to overcharge the NHS for anti-epileptic drugs in “overnight” skyrocketing prices. The Competition and Markets Authority (CMA) said it had provisionally found that Flynn and Covid-19 vaccine maker Pfizer violated competition …

Epilepsy affects some 50 million people worldwide and the pharmaceutical treatment of the disease is a tightrope walk, because the dose must be adapted precisely to each patient: “A little too little and it is not effective. A little too much. and it becomes toxic “. explains Professor Pablo Sinues. …

A new optogenetic tool, a light-controllable protein, has been characterized by researchers at the Ruhr-Universität Bochum (RUB). They used an opsin – a protein found in the brain and eyes – from zebrafish and introduced it into the brains of mice. Unlike other optogenetic tools, this opsin is not turned …

In Epilepsy and behavior editorial, the authors write that the FINTEPLA data demonstrate “an unprecedented level of seizure control” for treated patients living with Dravet syndrome, a severe and debilitating epilepsy of childhood. The authors also recognize FINTEPLA for obtaining clinically important results in outcomes reported by caregivers, such as …

Fintepla (fenfluramine) successfully managed the severe and difficult-to-treat seizures of a 20-year-old woman with Dravet syndrome, demonstrating the drug’s potential in real life to treat such difficult cases, researchers say. . “The deep and sustained response to [Fintepla] observed in this patient is similar to that seen in double-blind clinical …

DUBLIN – (COMMERCIAL THREAD)–The “Neuropeptide Y type 2 receptor (NPY Y2 or NPY2R receptor) – Drugs in development, 2021” drug pipelines was added to ResearchAndMarkets.com offer. Neuropeptide Y Receptor Type 2 pipeline (NPY Y2 Receptor or NPY2R) The target constitutes nearly 5 molecules. Neuropeptide Y type 2 receptor (NPY Y2 …